Revolution Medicines Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +1,031.4% | +29.3% | +157.3% | +30.1% | +10.0% | +153.9% | +24.1% | -8.0% | |
| – | +804.9% | +56.8% | +238.9% | +29.9% | +11.9% | +184.7% | +23.9% | -10.9% | |
| – | +666.5% | -76.1% | +525.9% | +4.1% | +48.8% | +331.3% | -22.0% | -29.3% | |
| – | +666.5% | +76.4% | +259.0% | +30.9% | +11.8% | +187.3% | +23.5% | -11.5% | |
| – | – | +19.6% | -26.8% | -7.3% | -21.2% | -73.2% | -100.0% | – | |
| – | – | -100.0% | – | – | – | +0.0% | – | – | |
| – | +30.8% | +4.0% | +24.6% | +700.2% | +3.5% | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | -1.7% | -1.7% | -1.8% | -1.8% | -1.8% | -1.9% | -1.5% | |
| – | +601.0% | -8.0% | +36.4% | +46.0% | -6.4% | +85.8% | +24.5% | +146.7% | |
| – | +302.1% | +40.9% | +9.6% | +27.9% | +2.7% | +132.1% | +13.9% | +77.2% | |
| – | – | +36.1% | +1,736.0% | +69.2% | +9.0% | +8.8% | +74.7% | +27.9% | |
| – | +56.2% | +117.7% | +10.6% | +11.5% | +51.6% | +190.0% | -11.9% | +18.7% | |
| – | +2,033.3% | +57.8% | +211.2% | +26.9% | +13.7% | +166.5% | +24.0% | -28.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +82.6% | +9.3% | +10.7% | +40.3% | +48.2% | +13.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.